Pack de 10 viales6 en stockAhorra un 26%PT-141 10 mg
Agonista de melanocortina bremelanotida
PT-141 bremelanotide research peptide, Australian-shipped. Lab-verified ≥99% purity.
Solo para uso en investigación. Este compuesto se vende estrictamente para investigación in vitro y fines de laboratorio, y no está destinado al consumo humano ni a uso terapéutico. Al comprar, confirma que es un investigador cualificado y acepta nuestro aviso legal completo.
Solo quedan 6 packs
Agonista sintético de receptores de melanocortina, estudiado por sus efectos sobre las vías neurales asociadas a la respuesta sexual en aplicaciones de investigación.
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist derived from the alpha-melanocyte-stimulating hormone (α-MSH) family. It is one of the most studied melanocortin-pathway research peptides outside of the tanning-active analogues. Quantum Labs supplies PT-141 as a lyophilised powder for Australian research applications.
Research on PT-141 has covered the central melanocortin pathway, particularly MC3R and MC4R receptor activation, and pre-clinical models of sexual-response signalling. Material is HPLC-verified to ≥99% purity and ships from Australian stock; supplied for laboratory research use only.
Mecanismo
La investigación sugiere un agonismo principal de MC4R, con efectos sobre el sistema nervioso central en marcadores neuroquímicos en sujetos de estudio.
Verificado por HPLC frente a una especificación de pureza ≥99 %. Analizado de forma independiente por laboratorios acreditados de terceros.
PT-141 — preguntas frecuentes
What is PT-141?
PT-141 (bremelanotide) is a synthetic melanocortin-receptor agonist studied in research models of central melanocortin-pathway signalling. It is one of the most-studied research peptides in the melanocortin family alongside the tanning-active analogues.
Is PT-141 legal in Australia?
PT-141 is restricted for compounded human therapeutic supply in Australia and remains available for research and laboratory use when supplied without therapeutic representation. Quantum Labs supplies PT-141 for research use only.
What receptors does PT-141 target?
PT-141 primarily activates the melanocortin-3 (MC3R) and melanocortin-4 (MC4R) receptors. Research has focused on the central melanocortin pathway, particularly downstream signalling in MC4R-rich brain regions.
What is bremelanotide?
Bremelanotide is the generic name for PT-141. It is a cyclic synthetic peptide derived from the α-MSH lineage. PT-141 is the research-code designation; bremelanotide is the pharmaceutical name.
What is the typical PT-141 research dosage?
Published research protocols have used wide dose ranges depending on the model and delivery route (intranasal, subcutaneous). Human dosing is not established. Researchers should consult primary literature for protocol-specific guidance.
Guías relacionadas con PT-141
Los investigadores también exploran
DestacadoPack de 10 vialesAhorra un 17%HGH
Polvo liofilizado10 IU · 4 strengths
Hormona de crecimiento humana recombinante
En 2 combinaciones
Pack de 10 vialesAhorra un 18%Tesamorelin
Polvo liofilizado10 mg · 3 strengths
Análogo estabilizado de GHRH
En 1 combinación
DestacadoPack de 10 vialesAhorra un 22%CJC-1295 + Ipamorelin
Polvo liofilizado5 mg + 5 mg
Combinación clásica de GHRH + mimético de grelina
En 2 combinaciones